Inari Medical, Inc. (NARI) Misses Q4 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ACCV
2. GMAB
3. IVBIY
4. IIB:IN
5. AZN
6. DRRD:IN
7. SMMT
8. RDY
9. CART
10. CLYM

Go back to Inari Medical, Inc. (NARI) Misses Q4 EPS by 1c

Inari Medical Reports Fourth Quarter and Full Year 2021 Financial Results

February 23, 2022 4:01 PM EST

IRVINE, Calif., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (Inari), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today reported financial results for its fourth quarter and full year ended December 31, 2021.

Fourth Quarter Revenue and Business Highlights:

Treated 7,700 patients, an increase of 15% over the third quarter. Over 90% of overall procedures and sequential procedural growth came from non-COVID patients.Generated revenue of $83.2 million in the... More